Health
Study: Targeting glycoprotein could improve response to cancer immunotherapy – News-Medical.Net
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for…
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for only a fraction of patients.
The analysis shone a light on one that popped up repeatedly in patients and mouse models that did not respond to immune checkpoint therapy: stanniocalcin-1, a glycoprotein whose role in both tumors and immunology is largely unknown.
By following the trail from this surprising thread, a University of Michigan Rogel…
-
General22 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General20 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News15 hours agoThe Laundry Lady secures $1M to fuel international expansion